Tumor microenvironment and therapeutic response

Wu, Ting, Dai, Yun·2017·Cancer Letters

Cited by (1,000)

Items 701–800 of 1,000

  1. Prediction and identification of immune genes related to the prognosis of patients with colon adenocarcinoma and its mechanisms
    Sihan Chen, Guodong Cao, Wei Wu, Yida Lu, Xiaobo He, Yang Lei, Ke Chen, Bo Chen, Maoming Xiong · 2020 · World Journal of Surgical Oncology
  2. Ultrasound Strain Elastography and Contrast‐Enhanced Ultrasound in Predicting the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer: A Nomogram Integrating Ki‐67 and Ultrasound Features
    Qi Liu, Lei Tang, Man Chen · 2021 · Journal of Ultrasound in Medicine
  3. AGT May Serve as a Prognostic Biomarker and Correlated with Immune Infiltration in Gastric Cancer
    Fanqi Wu, Longguo Zhang, Li Wang, Dekui Zhang · 2022 · International Journal of General Medicine
  4. A pan-cancer analysis confirms PTPN11’s potential as a prognostic and immunological biomarker
    Yapeng Cao, Haixia Duan, Ailing Su, Liran Xu, Baochang Lai · 2022 · Aging
  5. Heterogeneous expression of ACE2, TMPRSS2, and FURIN at single-cell resolution in advanced non-small cell lung cancer
    Zeyu Liu, Gu Xiaohua, Zhanxia Li, Shan Shan, Fengying Wu, Tao Ren · 2022 · Journal of Cancer Research and Clinical Oncology
  6. Immune Cells in Head-and-Neck Tumor Microenvironments
    Enar D. Jumaniyazova, А. V. Lokhonina, Dzhuliia Sh. Dzhalilova, Anna Mikhailovna Kosyreva, Timur Fatkhudinov · 2022 · Journal of Personalized Medicine
  7. Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma
    Zhongyue Liu, Binfeng Liu, Chengyao Feng, Chenbei Li, Hua Wang, Haixia Zhang, Ping Liu, Zhihong Li, Shasha He, Chao Tu · 2022 · Frontiers in Immunology
  8. The application basis of immuno-checkpoint inhibitors combined with chemotherapy in cancer treatment
    Ming-Yan Shi, Han-Ge Liu, Xiao-Hong Chen, Ye Tian, Zhi‐Nan Chen, Xiuli Wang · 2023 · Frontiers in Immunology
  9. The Role of TRL7/8 Agonists in Cancer Therapy, with Special Emphasis on Hematologic Malignancies
    Maria Leśniak, Justyna Lipniarska, Patrycja Majka, Weronika Kopyt, Monika Lejman, Joanna Zawitkowska · 2023 · Vaccines
  10. NNMT Is an Immune-Related Prognostic Biomarker That Modulates the Tumor Microenvironment in Pan-Cancer
    Wenxiu Liu, Meng Zhu, Xiaoming Li, Limian Er, Shengmian Li · 2023 · Disease Markers
  11. Genomic Landscape and Potential Regulation of RNA Editing in Drug Resistance
    Xu Zhou, Ramkrishna Mitra, Fei Hou, Shunheng Zhou, Lihong Wang, Wei Jiang · 2023 · Advanced Science
  12. Pan-cancer analysis reveals the prognostic and immunotherapeutic value of cytoskeleton-associated protein 2-like
    Bocun Yi, Qingfeng Fu, Zhiwen Zheng, Man Zhang, Dongze Liu, Zhengxin Liang, Shengxian Xu, Zhihong Zhang · 2023 · Scientific Reports
  13. Vasculogenic mimicry score identifies the prognosis and immune landscape of lung adenocarcinoma
    Weichang Yang, Zhouhua Li, Wenjun Wang, Juan Wu, Jinbo Li, Xiaotian Huang, Xinyi Zhang, Xiaoqun Ye · 2023 · Frontiers in Genetics
  14. Clusterin Is a Prognostic Biomarker of Lower-Grade Gliomas and Is Associated with Immune Cell Infiltration
    Xiaoyue Ren, Chao Chang, Teng Qi, Pengyu Yang, Yuanbo Wang, Xiaorui Zhou, Feng Guan, Xiang Li · 2023 · International Journal of Molecular Sciences
  15. Tumor Angiocrine Signaling: Novel Targeting Opportunity in Cancer
    Victor Oginga Oria, Janine Terra Erler · 2023 · Cells
  16. A MOF-based nanobomb for tumor microvascular occlusion and combined tumor starvation therapy and chemotherapy
    Xiaoyang Liu, Ya‐Xuan Zhu, Hao‐Ran Jia, Xinping Zhang, Ge Gao, Ke‐Fei Xu, Xin‐Wang Yu, Shihao Wang, Zixi Wang, Penghao Zhen et al. · 2023 · Materials Today Nano
  17. Modeling immunity in microphysiological systems
    Brian J. Kwee, Xiaoqing Li, Xinh-Xinh Nguyen, Courtney Campagna, Johnny Lam, Kyung Eun Sung · 2023 · Experimental Biology and Medicine
  18. Integrative pan-cancer analysis and experiment validation identified GLS as a biomarker in tumor progression, prognosis, immune microenvironment, and immunotherapy
    Dongming Li, Donghui Cao, Yangyu Zhang, Xinyi Yu, Yanhua Wu, Zhifang Jia, Jing Jiang, Xueyuan Cao · 2025 · Scientific Reports
  19. A stimuli-responsive combination therapy for recovering p53-inactivation associated drug resistance
    Leilei Guo, Yurui Xu, Anwei Zhou, Lei Zhang, Lei Sun, Ya Gao, Jianmei Chen, Xue Shan, Jikang Zhang, Junliang Ge et al. · 2019 · Materials Science and Engineering C
  20. Ocoxin Increases the Antitumor Effect of BRAF Inhibition and Reduces Cancer Associated Fibroblast-Mediated Chemoresistance and Protumoral Activity in Metastatic Melanoma
    Aitor Benedicto, Iera Hernandez-Unzueta, Eduardo Sanz, Joana Márquez · 2021 · Nutrients
  21. A novel panel based on immune infiltration and tumor mutational burden for prognostic prediction in hepatocellular carcinoma
    Chan Xie, Hewei Wu, Tao Pan, Xingrong Zheng, Xiaoàn Yang, Genglin Zhang, Yunwen Lian, Jiaxin Lin, Liang Peng · 2021 · Aging
  22. Glycolysis Changes the Microenvironment and Therapeutic Response Under the Driver of Gene Mutation in Esophageal Adenocarcinoma
    Lei Zhu, Fugui Yang, Xinrui Li, Qinchuan Li, Chunlong Zhong · 2021 · Frontiers in Genetics
  23. Macrocyclic Inhibitors of HGF-Activating Serine Proteases Overcome Resistance to Receptor Tyrosine Kinase Inhibitors and Block Lung Cancer Progression
    Vishnu C. Damalanka, Jorine J. L. P. Voss, Matthew W. Mahoney, Tina M. Primeau, Shunqiang Li, Lidija Klampfer, James W. Janetka · 2021 · Journal of Medicinal Chemistry
  24. A novel hypoxia-driven gene signature that can predict the prognosis of hepatocellular carcinoma
    Zhirui Zeng, Shan Lei, Jingya Wang, Yushi Yang, Jinzhi Lan, Qianting Tian, Tengxiang Chen, Xiao‐Jiang Hao · 2022 · Bioengineered
  25. Myeloid-derived suppressor cell-targeted virus-like particles synergistically activate innate immune response for cancer immunotherapy
    Zhixiong Zhu, Shuqin Cao, Hanwen Li, Zongliang Zhang, Qizhong Lu, Hexian Li, Luxuan Shen, Zeng Wang, Nian Yang, Jiayun Yu et al. · 2025 · Journal of Controlled Release
  26. A comprehensive review on overcoming the multifaceted challenge of cancer multidrug resistance: The emerging role of mesoporous silica nanoparticles
    Adel Mahmoudi Gharehbaba, Fatemeh Soltanmohammadi, Somayeh Vandghanooni, Morteza Eskandani, Khosro Adibkia · 2025 · Biomedicine & Pharmacotherapy
  27. Claudin-7 deficiency induces metabolic reprogramming of neutrophils in the colorectal cancer microenvironment
    Xiaoqing Liang, Dajin Yuan, Songyun Zhao, Jianbo Zhou, Kun Wang, Xiaoli Liu, Yin Liu, Huimin Li, Mengdi Hao, Wenbin Huang et al. · 2025 · Cell Death and Disease
  28. Engineering HLA-G-targeted extracellular vesicles nanoplatform for enhanced cancer therapy through precise cancer drug delivery
    Ming‐You Shie, Shi‐Wei Huang, Yeh Chen, Mei-Chih Chen, Chih‐Ming Pan, Cheng‐Yu Chen, Yen-Hong Lin, Minhua Yu, Kai‐Wen Kan, Shao‐Chih Chiu et al. · 2025 · Nature Communications
  29. Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q Codeletion
    Guanzhang Li, Ruoyu Huang, Wenhua Fan, Di Wang, Fan Wu, Fan Zeng, Mingchen Yu, You Zhai, Yuanhao Chang, Changqing Pan et al. · 2021 · Frontiers in Immunology
  30. Upregulation of MTA1 in Colon Cancer Drives A CD8+ T Cell-Rich But Classical Macrophage-Lacking Immunosuppressive Tumor Microenvironment
    Yantong Zhou, Peng Nan, Chunxiao Li, Hongnan Mo, Ying Zhang, Haijuan Wang, Dongkui Xu, Fei Ma, Haili Qian · 2022 · Frontiers in Oncology
  31. Molecular and Immune Profiling of Syngeneic Mouse Models Predict Response to Immune Checkpoint Inhibitors in Gastric Cancer
    Dagyeong Lee, Junyong Choi, Hye Jeong Oh, In‐Hye Ham, Sung Hak Lee, Sachiyo Nomura, Sang‐Uk Han, Hoon Hur · 2022 · Cancer Research and Treatment
  32. Pan-Cancer Analysis of OLFML2B Expression and Its Association With Prognosis and Immune Infiltration
    Pengbo Hu, Xiuyuan Zhang, Yiming Li, Liang Xu, Hong Qiu · 2022 · Frontiers in Genetics
  33. Genetic mutation and tumor microbiota determine heterogenicity of tumor immune signature: Evidence from gastric and colorectal synchronous cancers
    Weili Yang, Yaxing Zhao, Qiongxiang Ge, Xiaoli Wang, Jing Xiang Yang, Jingwen Zhao, Gang Liu, He Huang, Fei Cheng, Xiaoxi Wang et al. · 2022 · Frontiers in Immunology
  34. Integrative analysis of WDR12 as a potential prognostic and immunological biomarker in multiple human tumors
    Refaat Ali Eid, Muhammad Alaa Eldeen, Mohamed A. Soltan, Mubarak Mohammed Al-Shraim, Majed Aldehri, Leena S. Alqahtani, Ghadi Alsharif, Sarah M. Albogami, Ibrahim Jafri, Eman Fayad et al. · 2023 · Frontiers in Genetics
  35. BZW1 as an oncogene is associated with patient prognosis and the immune microenvironment in glioma
    Linyao Zhao, Congkuan Song, Yong Li, Fanen Yuan, Qingyu Zhao, Huimin Dong, Baohui Liu · 2023 · Genomics
  36. Crosstalk between endoplasmic reticulum stress and multidrug-resistant cancers: hope or frustration
    Bowen Qing, Song Wang, Yining Du, Can Liu, Wei Li · 2023 · Frontiers in Pharmacology
  37. Lung cancer organoids: models for preclinical research and precision medicine
    Yajing Liu, Yanbing Zhou, Pu Chen · 2023 · Frontiers in Oncology
  38. Biophysical control of plasticity and patterning in regeneration and cancer
    Nirosha J. Murugan, Solsa Cariba, Sawith Abeygunawardena, Nicolas Rouleau, Samantha L. Payne · 2023 · Cellular and Molecular Life Sciences
  39. CRISPR/Cas9-Mediated Customizing Strategies for Adoptive T-Cell Therapy
    Hyeseon Park, Yoo Kyung Kang, Gayong Shim · 2024 · Pharmaceutics
  40. Targeting the tumor microenvironment in primary central nervous system lymphoma: Implications for prognosis
    Hanping Shi, Xuefei Sun, Yuchen Wu, Qu Cui, Shengjun Sun, Nan Ji, Yuanbo Liu · 2024 · Journal of Clinical Neuroscience
  41. Targeting proliferating cell nuclear antigen (PCNA) for cancer therapy
    Caroline Krogh Søgaard, Marit Otterlei · 2024 · Advances in pharmacology
  42. Bioprinted Multi‐Composition Array Mimicking Tumor Microenvironments to Evaluate Drug Efficacy with Multivariable Analysis
    Gihyun Lee, Soo Jee Kim, Je‐Kyun Park · 2024 · Advanced Healthcare Materials
  43. The immunoregulatory role of gut microbiota in the incidence, progression, and therapy of breast cancer
    Kaiyang Xue, Jiawei Li, Ruijie Huang · 2024 · Frontiers in Cellular and Infection Microbiology
  44. An Immune‐Enhancing Injectable Hydrogel Loaded with Esketamine and DDP Promotes Painless Immunochemotherapy to Inhibit Breast Cancer Growth
    Xiali Yin, Yaohua Ke, Ying Liang, Shuxian Zhang, Ziqi Chen, Lixia Yu, Ming Jiang, Qin Liu, Xiaoping Gu · 2024 · Advanced Healthcare Materials
  45. Metal Peroxide Nanoparticles for Modulating the Tumor Microenvironment: Current Status and Recent Prospects
    Jagadeesh Rajaram, Yaswanth Kuthati · 2024 · Cancers
  46. Cell Segmentation With Globally Optimized Boundaries (CSGO): A Deep Learning Pipeline for Whole-Cell Segmentation in Hematoxylin-and-Eosin–Stained Tissues
    Zifan Gu, Shidan Wang, Ruichen Rong, Zhuo Zhao, Fangjiang Wu, Qin Zhou, Zhuoyu Wen, Zhikai Chi, Yisheng V. Fang, Yan Peng et al. · 2024 · Laboratory Investigation
  47. Immune‐Infiltrated Cancer Spheroid Model with Vascular Recirculation Reveals Temporally Dependent and Tissue‐Specific Macrophage Recruitment
    Feng Zhang, Kimia Asadi Jozani, Anushree Chakravarty, Dawn S. Y. Lin, Andrew Hollinger, Shravanthi Rajasekar, Boyang Zhang · 2025 · Advanced Healthcare Materials
  48. Transcripts 202 and 205 of IL-6 confer resistance to Vemurafenib by reactivating the MAPK pathway in BRAF(V600E) mutant melanoma cells
    Kun Zhao, Yanrong Lu, Younan Chen, Jingqiu Cheng, Wengeng Zhang · 2020 · Experimental Cell Research
  49. Comprehensive analysis of immune infiltration and gene expression for predicting survival in patients with sarcomas
    Hongmin Chen, YiJiang Song, Chuangzhong Deng, Yanyang Xu, Huaiyuan Xu, Xiaojun Zhu, Guohui Song, Qinglian Tang, Jinchang Lu, Jin Wang · 2020 · Aging
  50. Tristetraprolin, a Potential Safeguard Against Carcinoma: Role in the Tumor Microenvironment
    Diwen Zhang, Zhigang Zhou, Ruixia Yang, Sujun Zhang, Bin Zhang, Yanxuan Tan, Lingyao Chen, Tao Li, Jian Tu · 2021 · Frontiers in Oncology
  51. PSMC5 Promotes Proliferation and Metastasis of Colorectal Cancer by Activating Epithelial–Mesenchymal Transition Signaling and Modulating Immune Infiltrating Cells
    Zirui He, Xiao Feng Yang, Ling Huang, Leqi Zhou, Sen Zhang, Jing Ping Sun, Minhua Zheng, Junjun Ma, Bo Feng, Lu Zang · 2021 · Frontiers in Cell and Developmental Biology
  52. Improving ovarian cancer treatment decision using a novel risk predictive tool
    Zhenyi Xu, Jiali Song, Lei Cao, Zhiwei Rong, Wenjie Zhang, Jia He, Kang Li, Yan Hou · 2022 · Aging
  53. Versatile nanocomposite augments high-intensity focused ultrasound for high-efficacy sonodynamic therapy of glioma
    Yingyan Zheng, Dejun She, Huihui Huang, Lin Lin, Sunhui Chen, Yiping Lu, Li Liu, Zhiqing Pang, Bo Yin · 2022 · Nano Research
  54. Accurate treatment of small cell lung cancer: Current progress, new challenges and expectations
    Chenyue Zhang, Haiyong Wang · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  55. Interrogation of single-cell communications on microfluidic platforms
    Lü Huang, Yin Chen, Jianhua Zhou · 2022 · Cell Reports Physical Science
  56. Roles of IL-7R Induced by Interactions between Cancer Cells and Macrophages in the Progression of Esophageal Squamous Cell Carcinoma
    Yu Kitamura, Yu‐ichiro Koma, Kohei Tanigawa, Shuichi Tsukamoto, Yuki Azumi, Shoji Miyako, Satoshi Urakami, Takayuki Kodama, Mari Nishio, Manabu Shigeoka et al. · 2023 · Cancers
  57. Pancreatic Tumor‐Targeting Stemsome Therapeutics
    Jun‐Young Park, Jun Young Park, Yong‐Gyu Jeong, Joo‐Hwan Park, Yeon Ho Park, Sang‐Hyun Kim, Dongwoo Khang · 2023 · Advanced Materials
  58. Identification of potential biomarkers associated with immune infiltration in the esophageal carcinoma tumor microenvironment
    Zhicheng Wang, Meilin Chen, Yanbing Qiu, Yuqin Yang, Yumei Huang, Xiaoxu Li, Wenling Zhang · 2021 · Bioscience Reports
  59. Novel technologies in cfDNA analysis and potential utility in clinic
    Jie Li, Mengyue Xu, Junya Peng, Jingqiao Wang, Yupei Zhao, Wenming Wu, Xun Lan · 2021 · Chinese Journal of Cancer Research
  60. Uncovering gene and cellular signatures of immune checkpoint response via machine learning and single-cell RNA-seq
    Asaf Pinhasi, K. Yizhak · 2025 · npj Precision Oncology
  61. From immune exclusion to exhaustion: tumor microenvironment drives therapy response
    Nemanja Maletin · 2026 · Frontiers in Immunology
  62. Combining Immunoscore with Clinicopathologic Features in Cholangiocarcinoma: An Influential Prognostic Nomogram
    Zi-you Wu, Wei Shen, Juanqing Yue, Wenyan Yao, Shilei Liu, Yunpeng Jin, Ping Dong, Fei Ma, Xiangsong Wu, Wei Gong · 2020 · OncoTargets and Therapy
  63. GLI2 but not GLI1/GLI3 plays a central role in the induction of malignant phenotype of gallbladder cancer
    Shu Ichimiya, Hideya Onishi, Shinjiro Nagao, Satoko Koga, Kukiko Sakihama, Kazunori Nakayama, Akiko Fujimura, Yasuhiro Oyama, Akira Imaizumi, Yoshinao Oda et al. · 2021 · Oncology Reports
  64. A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular Carcinoma
    Xing Lai, Yakun Wu, Guoqing Hong, Jun-ke Li, Qing Luo, Jin Yuan, Guo-hua Dai, Shuang-quan Liu, Hua-Guo Feng · 2022 · Journal of Immunology Research
  65. ANXA2 is a potential biomarker for cancer prognosis and immune infiltration: A systematic pan-cancer analysis
    Yijie Ning, Yufei Li, Hongqin Wang · 2023 · Frontiers in Genetics
  66. Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma
    Yankuo Liu, Zhiyuan Shi, Jianzhong Zheng, Zeyuan Zheng, Huimin Sun, Zuodong Xuan, Yang Bai, Meiling Fu, Yifan Du, Chen Shao · 2023 · Frontiers in Immunology
  67. Small Leucine-Rich Proteoglycan PODNL1 Identified as a Potential Tumor Matrix-Mediated Biomarker for Prognosis and Immunotherapy in a Pan-Cancer Setting
    Geyang Dai, Yue Sun, Rui Wei, Ling Xi · 2023 · Current Issues in Molecular Biology
  68. Research on the biological mechanism and potential application of CEMIP
    Yang Liu, Gang Hu, Yuetong Li, Xinyi Kong, Kaming Yang, Zhenlin Li, Wanwen Lao, Jiaxin Li, Jianhua Zhong, Shitong Zhang et al. · 2023 · Frontiers in Immunology
  69. Intratumoral and peritumoral MRI-based radiomics prediction of histopathological grade in soft tissue sarcomas: a two-center study
    Liyuan Zhang, Yang Yang, Ting Wang, Xi Chen, Mingyue Tang, Junnan Deng, Zhen Cai, Wei Cui · 2023 · Cancer Imaging
  70. Hedgehog signaling and the glioma-associated oncogene in cancer radioresistance
    Li Zhang, Yuhan Zhang, Kaixuan Li, Shuai Xue · 2023 · Frontiers in Cell and Developmental Biology
  71. Long Non-Coding RNA NBR2 Suppresses the Progression of Colorectal Cancer by Downregulating miR-19a to Regulate M2 Macrophage Polarization
    Xiaoting Yang, Ye Luo, Mengying Li, Zhan Jin, Gao Chen, Chunchun Gan · 2023 · The Chinese Journal of Physiology
  72. Myeloid cell-expressed MNDA enhances M2 polarization to facilitate the metastasis of hepatocellular carcinoma
    Yanru Meng, Mengxin Zhang, Xinli Li, Xinxin Wang, Qian Dong, Hu Zhang, Yuanjun Zhai, Qin Song, Fuchu He, Chunyan Tian et al. · 2024 · International Journal of Biological Sciences
  73. Focused ultrasound as a treatment modality for gliomas
    Divine C. Nwafor, Derrick Obiri‐Yeboah, Faraz Fazad, William Blanks, Melike Mut · 2024 · Frontiers in Neurology
  74. Amphiregulin promotes activated regulatory T cell-suppressive function via the AREG/EGFR pathway in laryngeal squamous cell carcinoma
    Hang Li, Ruihua Fang, Renqiang Ma, Yudong Long, Rui Rochelle He, Huanhuan Lyu, Lin Chen, Yihui Wen · 2024 · Head & Face Medicine
  75. A novel USP4 inhibitor that suppresses colorectal cancer stemness by promoting β-catenin and Twist1 degradation
    Fengtian Li, Yi Zhou, Xinyue Lin, Yaxin Zhang, Qingyong Hu, Enen Zhao, H.‐B. Li, Xingyan Pan, Feng Shu, Kun Zhang et al. · 2025 · Journal of Translational Medicine
  76. Valproic acid inhibits the protective effects of stromal cells against chemotherapy in breast cancer: Insights from proteomics and systems biology
    Farnaz Barneh, Mona Salimi, Fatemeh Goshadrou, Minoo Ashtiani, Mehdi Mirzaie, Hakimeh Zali, Mohieddin Jafari · 2018 · Journal of Cellular Biochemistry
  77. Injectable Biomaterials for Treatment of Glioblastoma
    Alexa R. Anderson, Tatiana Segura · 2020 · Advanced Materials Interfaces
  78. Myeloid-Derived Suppressor Cells in Immune Microenvironment Promote Progression of Esophagogastric Junction Adenocarcinoma
    Ying Wang, Haiyan Sun, Ningning Zhu, Xianxian Wu, Zhilin Sui, Lei Gong, Zhentao Yu · 2021 · Frontiers in Oncology
  79. Effect of TRPM2-Mediated Calcium Signaling on Cell Proliferation and Apoptosis in Esophageal Squamous Cell Carcinoma
    Xingbang Wang, Yong Xiao, Mingming Huang, Bing Q. Shen, Haowei Xue, Kaile Wu · 2021 · Technology in Cancer Research & Treatment
  80. The critical function of metabolic reprogramming in cancer metastasis
    Sun‐Zhe Xie, Jun‐Jie Pan, Jianfeng Xu, Wenwei Zhu, Lun–Xiu Qin · 2022 · Aging and Cancer
  81. Dual-responsive nanosystem based on TGF-β blockade and immunogenic chemotherapy for effective chemoimmunotherapy
    Xiaoxian Huang, Lingfei Han, Ruyi Wang, Wanfang Zhu, Ning Zhang, Wei Qu, Wenyuan Liu, Fulei Liu, Feng Feng, Jingwei Xue · 2022 · Drug Delivery
  82. M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors
    Carla Barceló, Pol Sisó, Inés de la Rosa, Cristina Megino‐Luque, Raúl Navaridas, Óscar Maiques, Izaskun Urdanibia, Núria Eritja, X. Soria, Míriam Potrony et al. · 2022 · British Journal of Cancer
  83. Tumor Microenvironment Heterogeneity-Based Score System Predicts Clinical Prognosis and Response to Immune Checkpoint Blockade in Multiple Colorectal Cancer Cohorts
    Hufei Wang, Zhi Li, Suwen Ou, Yanni Song, Kangjia Luo, Zilong Guan, Lei Zhao, Rui Huang, Shan Yu · 2022 · Frontiers in Molecular Biosciences
  84. Pyroptosis impacts the prognosis and treatment response in gastric cancer via immune system modulation.
    Wanli Yang, Liaoran Niu, Xinhui Zhao, Lili Duan, Xiaoqian Wang, Yiding Li, Junfeng Chen, Wei Jie Zhou, Yujie Zhang, Daiming Fan et al. · 2022 · PubMed Central
  85. A pan-cancer analysis reveals the genetic alterations and immunotherapy of Piezo2 in human cancer
    Xin Zhe Liu, Yangpu Jia, Zhihui Wang, Zhaoxiong Zhang, Weihua Fu · 2022 · Frontiers in Genetics
  86. Identification of senescence-related subtypes, establishment of a prognosis model, and characterization of a tumor microenvironment infiltration in breast cancer
    Yanling Zhou, Liang Xiao, Guo Long, Jing Cao, Shuang Liu, Yongguang Tao, Ledu Zhou, Jianing Tang · 2022 · Frontiers in Immunology
  87. A comprehensive pancancer analysis reveals the potential value of RAR-related orphan receptor C (RORC) for cancer immunotherapy
    Shengfu He, Jiawen Yu, Weijie Sun, Yating Sun, Mingyang Tang, Bao Meng, Yanyan Liu, Jiabin Li · 2022 · Frontiers in Genetics
  88. Engineered exosome-mediated cobalt sulfide quantum dot targeted delivery for photothermal and chemodynamic anticancer therapy
    Jintao Yang, Qi Wang, Tianying Xing, Xu Wang, Guangping Li, Zhenhua Shang, Jiangtao Wu, Wen Chen, Tongwen Ou · 2023 · Journal of Drug Delivery Science and Technology
  89. Therapies Targeting Immune Cells in Tumor Microenvironment for Non-Small Cell Lung Cancer
    Wei Ye, Meiye Li, Ke-Wang Luo · 2023 · Pharmaceutics
  90. Highly expressed centromere protein L indicates adverse survival and associates with immune infiltration in hepatocellular carcinoma
    Zhili Zeng, Xiao Jiang, Zhibin Pan, Rui-Sheng Zhou, Zhuangteng Lin, Ying Chun Tang, Ying Jun Cui, Enxin Zhang, Zebiao Cao · 2021 · Aging
  91. Vocal fold fibroblasts promote angiogenesis in vocal fold leukoplakia by secreting pro-angiogenic factors
    Yinying Chu, Yi Fang, Haitao Wu, Jian Chen, Lei Cheng · 2022 · Auris Nasus Larynx
  92. Glioblastoma: two immune subtypes under the surface of the cold tumor
    Wu Xiong, Cong Li, Guang Kong, Bowen Wan, Siming Wang, Jin Fan · 2022 · Aging
  93. Microphysiological systems as models for immunologically ‘cold’ tumors
    Gaebler, Daniela, Hachey, Stephanie J., Hughes, Christopher C. W. · 2024 · Frontiers in Cell and Developmental Biology
  94. Decoding the Tumor-Associated Microbiota: From Origins to Nanomedicine Applications in Cancer Therapy
    Ruiqi Wang, Weizheng Li, Hongqian Cao, Lei Zhang · 2025 · Biology
  95. Targeted nano-drug delivery systems for tumor immunotherapy
    Shan Lian, Wenyong Yang, Yan Zeng, Ranran Tang, Kui Wang · 2025 · Journal of Pharmaceutical Analysis
  96. Dynamic Evolution of the Tumor Immune Microenvironment in Malignant Tumors and Emerging Therapeutic Paradigms
    Ying Hao Sun, Changjian Shao, Hongtao Duan, Zhaoyang Wang, Shaopeng Xu, Chao Wang, Jiawei Xiu, Jin Liu, Xuejiao Wang, Xin Yao et al. · 2025 · MedComm
  97. CAR-T cells in solid tumors: engineering, biomarkers, translational pathways and the road ahead
    Nada Saed Homod Al Shaer, Ibraheem Masoud, Aya Tleyjeh, Attas Alawi Al-Attas, Maryam Alawi Al-Attas, Mohammed Imran Khan, Ahmed Yaqinuddin · 2026 · Frontiers in Immunology
  98. Computerized Assessment of the Tumor-stromal Ratio and Proposal of a Novel Nomogram for Predicting Survival in Invasive Breast Cancer
    Qian Xu, Feng Xiao, Yuanyuan Chen, Jingping Yuan, Xiaohong Liu, Lin‐Wei Wang, Bin Xiong · 2021 · Journal of Cancer
  99. Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma
    Lu Zhang, Jianlong Li, Mengzhao Zhang, Lu Wang, Tao Yang, Qiuya Shao, Xiao Liang, Minghai Ma, Nan Zhang, Minxuan Jing et al. · 2021 · Frontiers in Genetics
  100. Construction and validation of a novel apoptosis-associated prognostic signature related to osteosarcoma metastasis and immune infiltration
    Yucheng Fu, Zhijian Jin, Yuhui Shen, Zhusheng Zhang, Meng Li, Zhuochao Liu, Guoyu He, Jintao Wu, Junxiang Wen, Qiyuan Bao et al. · 2022 · Translational Oncology